Home Analytical and clinical performance of three natriuretic peptide tests in the emergency room
Article
Licensed
Unlicensed Requires Authentication

Analytical and clinical performance of three natriuretic peptide tests in the emergency room

  • Cecile Gorissen , Ruben Baumgarten , Monique de Groot , Eric van Haren , Hans Kragten and Mathie Leers
Published/Copyright: May 7, 2007
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 45 Issue 5

Abstract

Background: The aim of the present study was to investigate the analytical and diagnostic utility of B-type natriuretic peptide (BNP) and the N-terminus of this prohormone, N-terminal pro-BNP (NT-pro-BNP) testing in the emergency department to identify acute congestive heart failure (CHF).

Methods: A blood sample taken from patients presenting to the emergency department with acute dyspnoea (n=80) was analyzed for natriuretic peptides using three different assays [Triage BNP (Biosite), Centaur BNP (Bayer) and Elecsys NT-pro-BNP (Roche)]. A cardiologist and a pulmonologist, blinded to the actual natriuretic peptide levels, reviewed all test results (including echocardiography, etc.) retrospectively and made a diagnosis of dyspnoea due to CHF or not.

Results: Analytical testing showed good correlation and coefficients of variation of less than 10% for all three assays. Cardiac-related dyspnoea was found in 40 patients (50%). NT-proBNP and BNP values were significantly elevated in these patients. For identifying patients with CHF, BNP and NT-proBNP scored equally well (area under the receiver operating characteristic curve of 0.78, 0.77 and 0.78 for the Biosite, Roche and Bayer assays, respectively).

Conclusions: In general, the different assays tested for BNP and NT-pro-BNP correlate very well in patients with suspected CHF and may aid in the risk stratification process in emergency departments. However, the value must always be interpreted in conjunction with other clinical information. It should also be considered that renal impairment can affect the results.

Clin Chem Lab Med 2007;45:678–84.


Corresponding author: Mathie P.G. Leers, PhD, Department of Clinical Chemistry and Haematology, Atrium Medical Centre Parkstad, P.O. Box 4446, 6401 CX Heerlen, The Netherlands Phone: +31-45-5767503,

Received: 2006-12-7
Accepted: 2007-2-15
Published Online: 2007-05-07
Published in Print: 2007-05-01

©2007 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. 6th Conference on Homocysteine Metabolism, World Congress on Hyperhomocysteinemia, Saarbruecken/Germany June 5-9, 2007
  2. The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes
  3. Cervical screening in the 21st century: the case for human papillomavirus testing of self-collected specimens
  4. Influence of apolipoprotein E polymorphism on serum lipid and lipoprotein changes: a 21-year follow-up study from childhood to adulthood. The Cardiovascular Risk in Young Finns Study
  5. Association of lipase lipoprotein polymorphisms with myocardial infarction and lipid levels
  6. Validation of a reverse-hybridization StripAssay for the simultaneous analysis of common α-thalassemia point mutations and deletions
  7. HLA-DQA1 and -DQB1 allele typing in southern Taiwanese women with breast cancer
  8. Association of a polymorphism in the promoter of the cellular retinoic acid-binding protein II gene (CRABP2) with increased circulating low-density lipoprotein cholesterol
  9. Frequency of two human glutathione-S-transferase omega-1 polymorphisms (E155 deletion and E208K) in Ovambo and Japanese populations using the PCR-based genotyping method
  10. Transthyretin amyloidosis in a patient of Iranian-Jewish extraction: a second Israeli-Jewish case
  11. Relationship between neurological outcome and early oxidative changes in erythrocytes in head injury patients
  12. Mesothelin family proteins and diagnosis of mesothelioma: analytical evaluation of an automated immunoassay and preliminary clinical results
  13. Prevalence of insulin resistance and prediction of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovary syndrome
  14. A simple high-throughput method for the determination of plasma methylmalonic acid by liquid chromatography-tandem mass spectrometry
  15. Effects of gestational and lactational choline deprivation on brain antioxidant status, acetylcholinesterase, (Na+,K+)- and Mg2+-ATPase activities in offspring rats
  16. Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell tumours
  17. Measurement of calcitonin by immunoassay analyzers
  18. Interference in a homogeneous assay for low-density lipoprotein cholesterol by lipoprotein X
  19. Quality indicators and specifications for key processes in clinical laboratories: a preliminary experience
  20. Analytical and clinical performance of three natriuretic peptide tests in the emergency room
  21. Quality of serum creatinine measurement in light of EQA programs
  22. Decreased plasmalogen concentration as a surrogate marker of oxidative stress in patients presenting with acute coronary syndromes or supraventricular tachycardias
  23. Comparison between AlaTOP and IP8 inhalant panels on the Immulite 2000 analyzer
  24. External quality assessment of urinary methylmalonic acid quantification – results of a pilot study
Downloaded on 15.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2007.119/html
Scroll to top button